Advanced Filters
noise

ovarian-cancer Clinical Trials

A listing of ovarian-cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 561 clinical trials
D Dr. Lucy Gilbert, MD,MSc,FRCOG

DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics

This study aims to develop and validate a test for diagnosing ovarian and endometrial cancers early. It relies on detecting somatic mutations that are associated with these cancers in a biofluids sample taken from the cervix and the uterine cavity.

18 years of age Female Phase N/A
D Dominique GENRE, MD

Institut Paoli Calmettes Ovarian Cancer Database

Database of Institut Paoli-Calmettes patients diagnosed with ovarian cancer

18 - 95 years of age Female Phase N/A
D Dr. Lucy Gilbert, MD,MSc,FRCOG

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.

45 years of age Female Phase N/A
Y Yuan Li, Doctor

A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration

The aim of this project is to establish a bidirectional multicenter cohort of hereditary ovarian cancer and to describe the clinicopathologic features of hereditary ovarian cancer patients in our country. The risk prediction model of ovarian cancer for Chinese was established by following-up analysis of clinical and pathological information, genetic …

18 years of age Female Phase N/A
D Daniel Fleming, DO

A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass

Ovarian cancer is a serious health risk with the highest death rate among gynecological cancers. Unfortunately, it's only possible to definitively diagnose ovarian cancer after surgery, as there are no reliable tests to determine if an ovarian abnormality is cancerous or benign before surgery. Cleo Diagnostics have developed a new …

18 years of age Female Phase N/A
R Roberto Pola, PhD; MD

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.

18 years of age Female Phase N/A
J Jeong-Yeol Park, M.D., Ph.D.

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.

18 years of age Female Phase N/A
S Saeed Jortani, Ph.D.

EXoPERT EMERALD Clinical Study

Invitro diagnostic test for multiple cancer diagnosis for patients with early-stage cancers by analyzing surface-enhanced Ramen spectroscopy (SERS) profiles of extracellular vesicles (EV) using artificial intelligence.

45 years of age All Phase N/A
M Morgane PERRIN, Dr

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

GynRAN is an international, multicentre, transversal, diagnostic and non-interventional study carried out in gynecology-obstetrics/gynecological oncology departments that aims to identify a diagnostic signature for gynecological pathologies by analyzing of coding and non-coding RNA contained in patients saliva. The study population consists of patients with clinically symptomatic females with one or …

18 years of age Female Phase N/A
L Lei Li, M.D.

ctDNA Methylation for Epithelial Ovarian Cancer

Ovarian cancer is one of the most dangerous and predominant gynecological cancers, with a high cancer-related mortality rate in women. However, current testing methods are still limited, and if detected early, patients have a five-year survival rate of 92%. Therefore, early diagnosis and detection are crucial for diagnosing and treating …

18 years of age Female Phase N/A

Simplify language using AI